Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

MiNK Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.0-3.8689.6
            Revenue growth -100.0%-100.6% 
Cost of goods sold0.00.00.019,146.1
Gross profit0.00.0-3.8-18,456.4
            Gross margin  100.0%-2676.3%
Selling, general and administrative0.00.0  
Research and development  9.5 
General and administrative0.00.01.33,828.0
EBIT0.00.0-14.6-22,284.5
            EBIT margin  381.1%-3231.4%
Pre-tax income-28.0-30.2-16.2-23,802.2
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-28.0-30.2-16.2-23,802.2
            Net margin  422.8%-3451.5%
 
Diluted EPS($0.83)($1.16)($0.67)($0.99)
Shares outstanding (diluted)33.726.024.124,059.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy